BeeWell

Trials & centers

Ask your doctor

Pick a condition
Breast cancerLung cancerColorectal cancerProstate cancerPancreatic cancerOvarian cancerLeukemiaLymphomaBrain tumorMelanomaLiver cancerMultiple myeloma

Recruiting trials

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

Phase 2 Recruiting

  • UC San Diego Moores Cancer Center, La Jolla, California, United States
  • Yale University, New Haven, Connecticut, United States
  • Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States
  • More sites
Official record

Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma

Phase 1 & 2 Recruiting

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States
Official record

A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

Phase 1 Recruiting

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Official record

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 & 2 Recruiting

  • Sylvester Comprehensive Cancer Center, Miami, Florida, United States
  • Moffitt Cancer Center - McKinley Drive, Tampa, Florida, United States
  • Emory University Hospital, Atlanta, Georgia, United States
  • More sites
Official record

A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy

Phase 2 Recruiting

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
  • More sites
Official record

Horizon Two: HR NDMM (MMRC-100)

Phase 2 Recruiting

  • City of Hope, Duarte, California, United States
  • Emory University, Atlanta, Georgia, United States
  • UChicago Medicine, Chicago, Illinois, United States
  • More sites
Official record

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Phase 3 Recruiting

  • Study Site 102, St. Petersburg, Florida, United States
  • Study Site 101, Fort Wayne, Indiana, United States
  • Study Site 105, Westbrook, Maine, United States
  • More sites
Official record

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Phase 3 Recruiting

  • University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center, Anchorage, Alaska, United States
  • More sites
Official record
ClinicalTrials.gov

NCI-designated centers

Comprehensive & clinical

Alabama

Arizona

California

Colorado

Connecticut

District of Columbia

  • Georgetown Lombardi Comprehensive Cancer Center

    Washington, District of Columbia

    NCI listingPlan a trip

Florida

Georgia

Hawai'i

Illinois

Indiana

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center

    Indianapolis, Indiana

    NCI listingPlan a trip

Iowa

Kansas

Kentucky

Maryland

  • Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland

    NCI listingPlan a trip

  • University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

    Baltimore, Maryland

    NCI listingPlan a trip

Massachusetts

Michigan

Minnesota

Missouri

Nebraska

New Hampshire

New Jersey

New Mexico

  • University of New Mexico Cancer Research and Treatment Center

    Albuquerque, New Mexico

    NCI listingPlan a trip

New York

North Carolina

Ohio

Oklahoma

Oregon

Pennsylvania

South Carolina

Tennessee

Texas

Utah

Virginia

Washington

  • Fred Hutchinson/University of Washington/Seattle Children's Cancer Consortium

    Seattle, Washington

    NCI listingPlan a trip

Wisconsin

NCI-Designated Cancer Centers, June 10, 2026